Specialty Pharmaceuticals Distributor | Morris & Dickson

The right combination of products, pricing, and service for pharmacy owners

As specialty pharmaceuticals and biologics continue to grow, Morris & Dickson is the partner of choice for ensuring access, handling, and delivery of complex therapies—including exclusive, limited distribution, and hard-to-source products, with expanded access to plasma-derived therapies through ProdigyMD.

We offer best-in-class cold-chain distribution, protecting product integrity from origin to final destination, supported by high-touch service and personalized attention.

Supply is our specialty

Specialty pharmacies rely on M&D for the timely delivery of therapies used to treat complex and serious conditions. Morris & Dickson offers more than 30,000 pharmaceutical and healthcare SKUs, with dependable access to specialty, limited distribution, and hard-to-source products.

Our expansive inventory of pharmaceuticals includes:

Brand Name
Generics
Specialty
Vaccines
OTC
Home Health
Plasma
Biosimilars

Expansive Portfolio

Biosimilars, generic injectables, and specialty therapies—including over 1,000 refrigerated items handled for daily delivery across 38 therapeutic classes, with expanded access to plasma-derived and hard-to-source products through ProdigyMD.

Cold-Chain Expertise and Security Control

Dedicated Specialty Distribution and Unit of Use refrigerated area, as well as Aerosafe and Coldtainer capabilities that ensure product tracking and integrity.

Cost Management

BeaconMD, a group purchasing organization supporting cost containment on specialty items for community clinics and infusion centers

Personalized Product Support

Dedicated and experienced account team to support product access and brand success

Recognizing the importance and impact of the growing specialty products market, Morris and Dickson is committed to expanding the number of specialty products available through M&D Specialty Distribution.

Jody Hatcher, CEO — Morris & Dickson

IN THE NEWS

Specialty pharmacy and pharmaceutical industry news from Morris & Dickson.

May 19, 2026

Chronic Pain Management in 2026: A Practical Guide for Pharmacists Navigating Safety, Compliance, and Patient Care

Read More
May 5, 2026

Cholesterol Management in 2026: What’s Changed and What Pharmacists Need to Do Now

Read More
April 2, 2026

Loargys® (pegzilarginase-nbln) now available to patients in the U.S. just 5 weeks after FDA approval

Read More
More News